Provention Bio, Inc. (NASDAQ:NASDAQ:PRVB) Q1 2022 Earnings Conference Call May 5, 2022, 8:00 AM ET Company Participants Ashleigh Palmer – Co-Founder, President, Chief Executive Officer.
/PRNewswire/ Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated.
/PRNewswire/ Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated.
RED BANK, N.J., March 4, 2022 /PRNewswire/ Provention Bio, Inc. , a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the Company. | March 4, 2022